![Mark Shearman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Shearman
Amministratore Delegato presso
Aprinoia Therapeutics, Inc. /US/
Profilo
Mark S.
Shearman is currently the Chief Executive Officer & Director at Aprinoia Therapeutics, Inc. He previously held positions as the Executive Director-Neuroscience at Merck & Co., Inc., the Executive Director at Merck Research Laboratories Massachusetts LLC, and the Senior Director-Cellular & Molecular Neuroscience at Merck Sharp & Dohme Research Laboratories Neuroscience Research.
He also served as the Senior VP-Research & Early Development at Merck KGaA and the Chief Scientific Officer & Vice President at Beacon Therapeutics (USA), Inc. Dr. Shearman's most recent former position was as the Chief Scientific Officer & Executive VP at Editas Medicine, Inc. He received his undergraduate degree from the University of Bristol and his doctorate from The University of Nottingham.
Posizioni attive di Mark Shearman
| Società | Posizione | Inizio |
|---|---|---|
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on neurodegenerative diseases | Amministratore Delegato | 14/07/2023 |
Precedenti posizioni note di Mark Shearman
| Società | Posizione | Fine |
|---|---|---|
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Direttore Tecnico/Scientifico/R&S | 20/04/2021 |
| MERCK KGAA | Corporate Officer/Principal | 01/01/2015 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Direttore/Membro del Consiglio | 01/07/2009 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2009 |
Merck Sharp & Dohme Research Laboratories Neuroscience Researc | Corporate Officer/Principal | 01/01/2005 |
Formazione di Mark Shearman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
87
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Merck Sharp & Dohme Research Laboratories Neuroscience Researc | |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on neurodegenerative diseases | Health Technology |
